Management of hyperglycaemia and steroid (glucocorticoid) therapy
Joint British Diabetes Societies for Inpatient Care
People with diabetes who are undergoing treatment with glucocorticoids are at an increased risk of glucocorticoid-induced hyperglycaemia. The use of steroids in people without a known diagnosis of diabetes may result in glucocorticoid-induced diabetes. Some patients may develop hyperglycaemia at a lower glucocorticoid dose, so clinical vigilance is, therefore, recommended with steroid therapy at any dose.
This Guidelines summary provides recommendations on treatment and monitoring, which is outlined in two concise management algorithms.